Clearbridge Health acquired the vaccines from manufacturers in China, including China National Biotec Group Company Limited (CNBG) and Beijing Institute of Biological Product Co, a subsidiary of CNBG.
Clearbridge Health's second batch of the Sinopharm Covid-19 vaccine has arrived in Singapore, according to a filing to the Singapore Exchange (SGX) on Sept 22.
The group’s first shipment of the Sinopharm vaccine arrived on August 28 and was fully allocated by early September.
